Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MAXCYTE, INC. | Director | Common Stock | 269K | $1M | $3.72 | Nov 1, 2024 | Direct |
NOVAVAX INC | President and CEO, Director | Common Stock | 36.5K | $155K | $4.26 | Dec 14, 2022 | Direct |
NOVAVAX INC | President and CEO, Director | Restricted Stock Units | 6.97K | $39.6K | $5.69 | Dec 14, 2022 | Direct |
MAXCYTE, INC. | Director | Stock Option (right to buy) | 40.7K | Jun 11, 2024 | Direct | ||
MAXCYTE, INC. | Director | Employee Stock Option (right to buy) | 0 | Nov 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MXCT | MAXCYTE, INC. | Nov 1, 2024 | 3 | -$175K | 4 | Nov 5, 2024 | Director |
MXCT | MAXCYTE, INC. | Oct 1, 2024 | 6 | -$177K | 4 | Oct 2, 2024 | Director |
MXCT | MAXCYTE, INC. | Sep 3, 2024 | 6 | -$190K | 4 | Sep 5, 2024 | Director |
MXCT | MAXCYTE, INC. | Jun 11, 2024 | 2 | $0 | 4 | Jun 13, 2024 | Director |
MXCT | MAXCYTE, INC. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
NVAX | NOVAVAX INC | Dec 14, 2022 | 3 | -$40K | 4 | Dec 16, 2022 | President and CEO, Director |
NVAX | NOVAVAX INC | Sep 26, 2022 | 3 | -$41.1K | 4 | Sep 28, 2022 | President and CEO, Director |
MXCT | MAXCYTE, INC. | Jun 29, 2022 | 1 | $0 | 4 | Jul 8, 2022 | Director |
NVAX | NOVAVAX INC | Mar 10, 2022 | 2 | $0 | 4 | Mar 14, 2022 | President and CEO, Director |
NVAX | NOVAVAX INC | Dec 14, 2021 | 3 | -$567K | 4 | Dec 16, 2021 | President and CEO, Director |
NVAX | NOVAVAX INC | Oct 4, 2021 | 14 | -$6.37M | 4 | Oct 5, 2021 | President and CEO, Director |
NVAX | NOVAVAX INC | Oct 1, 2021 | 27 | -$7.25M | 4 | Oct 5, 2021 | President and CEO, Director |
NVAX | NOVAVAX INC | Sep 26, 2021 | 3 | -$785K | 4 | Sep 28, 2021 | President and CEO, Director |
MXCT | MAXCYTE, INC. | Aug 9, 2021 | 1 | $0 | 4 | Aug 11, 2021 | Director |
MXCT | MAXCYTE, INC. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |
NVAX | NOVAVAX INC | Jul 1, 2021 | 30 | -$15.1M | 4 | Jul 6, 2021 | President and CEO, Director |